KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Working Capital Changes: 2013-2025

Historic Other Working Capital Changes for Ionis Pharmaceuticals (IONS) over the last 13 years, with Sep 2025 value amounting to $158.0 million.

  • Ionis Pharmaceuticals' Other Working Capital Changes rose 579.11% to $158.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.2 million, marking a year-over-year increase of 159.18%. This contributed to the annual value of -$156.8 million for FY2024, which is 564.47% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Other Working Capital Changes of $158.0 million as of Q3 2025, which was up 860.60% from -$20.8 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Other Working Capital Changes ranged from a high of $158.0 million in Q3 2025 and a low of -$62.7 million during Q2 2024.
  • Over the past 3 years, Ionis Pharmaceuticals' median Other Working Capital Changes value was -$14.7 million (recorded in 2023), while the average stood at $39,364.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Other Working Capital Changes tumbled by 478.30% in 2021 and then spiked by 817.28% in 2023.
  • Over the past 5 years, Ionis Pharmaceuticals' Other Working Capital Changes (Quarterly) stood at -$11.2 million in 2021, then crashed by 41.03% to -$15.8 million in 2022, then plummeted by 165.38% to -$42.0 million in 2023, then soared by 65.94% to -$14.3 million in 2024, then skyrocketed by 579.11% to $158.0 million in 2025.
  • Its Other Working Capital Changes stands at $158.0 million for Q3 2025, versus -$20.8 million for Q2 2025 and -$13.7 million for Q1 2025.